Scientific Reports · 2018 · 90 citations · 44 references
EngineeringBioengineeringBiomedical EngineeringDrug DeliveryTissue EngineeringTumor MicroenvironmentAngiogenesis In CancerMetastatic Breast CancerMicrofluidic DevicesMicrofluidic SystemsMicrofluidicsTumor Microenvironment Interactions3D Tumor ModelsBreast Cancer Tumor MicroenvironmentCell Type MappingEndothelial-stromal InteractionsMicrovascular Network FlowMicrovascular Network FormationTumor Angiogenesis ModelsVascularized Tissue Models
Assessment of anti-cancer drug efficacy in in vitro three-dimensional (3D) bioengineered cancer models provides important contextual and relevant information towards pre-clinical translation of potential drug candidates. However, currently established models fail to sufficiently recapitulate complex tumor heterogeneity. Here we present a chip-based tumor-mimetic platform incorporating a 3D in vitro breast cancer model with a tumor-mimetic microvascular network, replicating the pathophysiological architecture of native vascularized breast tumors. The microfluidic platform facilitated formation of mature, lumenized and flow-aligned endothelium under physiological flow recapitulating both high and low perfused tumor regions. Metastatic and non-metastatic breast cancer cells were maintained in long-term 3D co-culture with stromal fibroblasts in a poly(ethylene glycol)-fibrinogen hydrogel matrix within adjoining tissue chambers. The interstitial space between the chambers and endothelium contained pores to mimic the "leaky" vasculature found in vivo and facilitate cancer cell-endothelial cell communication. Microvascular pattern-dependent flow variations induced concentration gradients within the 3D tumor mass, leading to morphological tumor heterogeneity. Anti-cancer drugs displayed cell type- and flow pattern-dependent effects on cancer cell viability, viable tumor area and associated endothelial cytotoxicity. Overall, the developed microfluidic tumor-mimetic platform facilitates investigation of cancer-stromal-endothelial interactions and highlights the role of a fluidic, tumor-mimetic vascular network on anti-cancer drug delivery and efficacy for improved translation towards pre-clinical studies.
44
Caroline F. Thorn, Connie Oshiro, Sharon Marsh et al. · Pharmacogenetics and Genomics · 2010 · 1.6K citations · Full text
Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
Yoshinori Imamura, Toru Mukohara, Yohei Shimono et al. · Oncology Reports · 2015 · 858 citations · Full text
Medicine, Cancer Biology, Oncology +15